March 8, 2022 Now Recruiting: CHIEF MEDICAL OFFICER SARC is seeking a part-time Chief Medical Officer (CMO). The CMO (a newly created role for SARC) will work in partnership with the Chief Executive Officer (CEO) and Chief Scientific … Read more
February 15, 2022 Together We Can Change Patient Outcomes The Sarcoma field is small, and the need for fostered collaborations is critical. Learn about our 2022 fundraising goals and explore how you can partner with us. Read more
November 29, 2021 November 11, 2021 SARC Semiannual Meeting Thank you for attending the 2021 SARC Semiannual Virtual Meeting on November 11, 2021. If you were not able to join the virtual event please view the agenda along with … Read more
November 24, 2021 SARC Sets Goal to Raise Funds for Clinical Trial SARC042 Together we give. Giving Tuesday is on Tuesday, November 30. It is a designated day each year to encourage charitable giving to support those who need our help. By donating, … Read more
November 10, 2021 SARC CAREER DEVELOPMENT PROGRAM: Applicants’ orientation/information session and Q&A (November 30, 2021, noon – 1 pm ET) An informational session for the SARC Career Development Award LOIs will be held Tuesday, November 30, 2021, noon – 1 pm ET. The session will be led by Dr. Jonathan … Read more
October 22, 2021 SARC Appoints Dr. Jonathan Fletcher To New Role of Chief Scientific Officer ANN ARBOR, MI October 22, 2021 – SARC (Sarcoma Alliance for Research Through Collaboration) is pleased to announce that Jonathan Fletcher, M.D., has been appointed Chief Scientific Officer (CSO), a … Read more
October 12, 2021 SARC 2022 Career Development Award SARC is pleased to announce our 2022 Career Development Award (CDA) funding opportunity. Past graduates (link here) of the SARC CDA program are pursuing productive independent careers at leading institutions … Read more
Epithelioid Sarcoma White Paper Published The Epithelioid Sarcoma Collaborative and SARC partner to help identify priority areas for new efforts to better inform patients, caregivers, and care providers. Read more
August 31, 2021 SARC024 Texas Children’s Cancer and Hematology Centers is now open to enrollment in SARC024 (Regorafenib/Refractory Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcomas). SARC024 sites include: • Atrium Health Levine Cancer Institute (Atlanta, GA)• … Read more
July 30, 2021 SARC appoints Chief Scientific Officer SARC is pleased to announce that Dr. Jonathan Fletcher has been appointed Chief Scientific Officer. Dr. Fletcher is a lab-based medical and pediatric oncologist at Harvard Medical School, Brigham and Women’s … Read more